Selective laser trabeculoplasty: a review of repeatability
阅读量：1055
DOI：10.21037/aes.2019.05.01
发布日期：2019-05-21
作者：
Yutong Guo ,Ariadni Ioannidou ,Philip Jute
展开更多 '%20fill='white'%20fill-opacity='0.01'/%3e%3cmask%20id='mask0_3477_29692'%20style='mask-type:luminance'%20maskUnits='userSpaceOnUse'%20x='0'%20y='0'%20width='16'%20height='16'%3e%3crect%20id='&%23232;&%23146;&%23153;&%23231;&%23137;&%23136;_2'%20x='16'%20width='16'%20height='16'%20transform='rotate(90%2016%200)'%20fill='white'/%3e%3c/mask%3e%3cg%20mask='url(%23mask0_3477_29692)'%3e%3cpath%20id='&%23232;&%23183;&%23175;&%23229;&%23190;&%23132;'%20d='M14%205L8%2011L2%205'%20stroke='%23333333'%20stroke-width='1.5'%20stroke-linecap='round'%20stroke-linejoin='round'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
关键词
Selective laser trabeculoplasty (SLT)
repeatability
repeat
glaucoma
摘要
Abstract: The efficacy of selective laser trabeculoplasty (SLT) to treat open-angle glaucoma (OAG) and ocular hypertension (OHT) has been increasingly substantiated lately. Repeated SLT is usually needed to control intraocular pressure (IOP), be it as primary or adjunctive therapy. We review the studies available, in terms of SLT repeatability; and conclude comparable efficacy, with success rate, duration and complications similar to those in initial SLT.
全文
基金
暂无基金信息
参考文献
1. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 1998;105:2082-8; discussion 2089-90.
2. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 2001;108:773-9.
3. Latina MA, Park C. Selective targeting of trabecular meshwork cells: In vitro studies of pulsed and CW laser interactions. Exp Eye Res 1995;60:359-71.
4. Cvenkel B, Hvala A, Drnovsek-Olup B, et al. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med 2003;33:204-8.
5. Waisbourd M, Katz LJ. Selective laser trabeculoplasty as a first-line therapy: a review. Can J Ophthalmol 2014;49:519-22.
6. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clin Ophthalmol 2010;5:5-10.
7. Lai JS, Chua JK, Tham CC, et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol 2004;32:368-72.
8. Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clin Ophthalmol 2015;9:833-41.
9. Ansari E. IOP Maintenance in SLT-treated Eyes following Subsequent Phacoemulsification and IOL. J Curr Glaucoma Pract 2013;7:17-8.
10. Zhou Y, Aref AA. A review of selective laser trabeculoplasty: recent findings and current perspectives. Ophthalmol Ther 2017;6:19.
11. Hong BK, Winer JC, Martone JF, et al. Repeat selective laser trabeculoplasty. J Glaucoma 2009;18:180-3.
12. Avery N, Ang GS, Nicholas S, et al. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. Int Ophthalmol 2013;33:501-6.
13. Khouri AS, Lin J, Berezina TL, et al. Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response. Middle East Afr J Ophthalmol 2014;21:205-9.
14. Ayala M. Intraocular pressure reduction after initial failure of selective laser trabeculoplasty(SLT). Graefe’s Arch. Graefes Arch Clin Exp Ophthalmol 2014;252:315-20.
15. Khouri AS, Lari HB, Berezina TL, et al. Long-term efficacy of repeat selective laser trabeculoplasty. J Ophthalmic Vis Res 2014;9:444-8.
16. Polat J, Grantham L, Mitchell K, et al. Repeatability of selective laser trabeculoplasty. Br J Ophthalmol 2016;100:1437-41.
17. Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmol 2016;16:128.
18. Durr GM, Harasymowycz P. The effect of repeat 360-degree selective laser trabeculoplasty on intraocular pressure control in open-angle glaucoma. J Fr Ophtalmol 2016;39:261-4.
19. Nagar M, Ogunyomade A, O’Brart D, et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 2005;89:1413-7.
20. Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. Br J Ophthalmol 2009;93:497-501.
21. Lee R, Hitnik C. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario health insurance plan. Can J Ophthalmol 2006;41:449-56.
22. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 2019;393:1505-16.
23. Lee JW, Wong MO, Liu CC, et al. Optimal selective laser trabeculoplasty energy for maximal intraocular pressure reduction in open-angle glaucoma. J Glaucoma 2015;24:e128-31.
24. Zhang HY, Qin YJ, Yang YF, et al. Intraocular pressure-lowering potential of subthreshold selective laser trabeculoplasty in patients with primary open-angle glaucoma. J Ophthalmol 2016;2016:2153723